Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3714813> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Q3714813 subject Q18924462.
- Q3714813 subject Q5920511.
- Q3714813 subject Q6946436.
- Q3714813 subject Q7486806.
- Q3714813 subject Q8529670.
- Q3714813 subject Q8919936.
- Q3714813 subject Q8955377.
- Q3714813 abstract "Doxefazepam (marketed under brand name Doxans) is a benzodiazepine derivative drug developed by Schiapparelli in the 1970s. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used therapeutically as a hypnotic. According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic in laboratory animals. Section 5.5 of the article Doxefazepam in volume 66 of the World Health Organization's (WHO) and International Agency for Research on Cancer's (IARC) IARC Monographs On The Evaluation Of Carcinogenic Risks To Humans, an article describing the carcinogenic/toxic effects of doxefazepam on humans and experimental animals, states that there is "inadequate evidence in humans for the carcinogenicity of doxefazepam" and limited evidence in experimental for the carcinogenicity of doxefazepam," and concluded that the overall evaluation of the substance's carcinogenicity to humans is "not classifiable."".
- Q3714813 atcPrefix "N05".
- Q3714813 atcSuffix "CD12".
- Q3714813 casNumber "40762-15-0".
- Q3714813 fdaUniiCode "231RV72C8L verifiedrevid = 457288969".
- Q3714813 iupacName "-2-(2-hydroxyethyl)-2,5-diazabicyclo".
- Q3714813 iupacName "9-chloro-6-(2-fluorophenyl)-4-hydroxy".
- Q3714813 iupacName "[5.4.0]undeca-5,8,10,12-tetraen-3-one".
- Q3714813 pubchem "38668".
- Q3714813 thumbnail Doxefazepam.svg?width=300.
- Q3714813 wikiPageExternalLink mono66-7.pdf.
- Q3714813 wikiPageExternalLink pim924.htm.
- Q3714813 wikiPageWikiLink Q1225289.
- Q3714813 wikiPageWikiLink Q187661.
- Q3714813 wikiPageWikiLink Q18924462.
- Q3714813 wikiPageWikiLink Q418998.
- Q3714813 wikiPageWikiLink Q552168.
- Q3714813 wikiPageWikiLink Q576618.
- Q3714813 wikiPageWikiLink Q5920511.
- Q3714813 wikiPageWikiLink Q62903.
- Q3714813 wikiPageWikiLink Q62962.
- Q3714813 wikiPageWikiLink Q6946436.
- Q3714813 wikiPageWikiLink Q7486806.
- Q3714813 wikiPageWikiLink Q7817.
- Q3714813 wikiPageWikiLink Q83871.
- Q3714813 wikiPageWikiLink Q847705.
- Q3714813 wikiPageWikiLink Q8529670.
- Q3714813 wikiPageWikiLink Q8919936.
- Q3714813 wikiPageWikiLink Q8955377.
- Q3714813 wikiPageWikiLink Q9368.
- Q3714813 wikiPageWikiLink Q9377.
- Q3714813 atcPrefix "N05".
- Q3714813 atcSuffix "CD12".
- Q3714813 casNumber "40762".
- Q3714813 iupacName "-2".
- Q3714813 iupacName "9".
- Q3714813 iupacName "[5.4.0]undeca-5,8,10,12-tetraen-3-one".
- Q3714813 pubchem "38668".
- Q3714813 unii "231".
- Q3714813 type ChemicalSubstance.
- Q3714813 type Drug.
- Q3714813 type ChemicalObject.
- Q3714813 type Thing.
- Q3714813 type Q8386.
- Q3714813 comment "Doxefazepam (marketed under brand name Doxans) is a benzodiazepine derivative drug developed by Schiapparelli in the 1970s. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. It is used therapeutically as a hypnotic. According to Babbini and colleagues in 1975, this derivative of flurazepam was between 2 and 4 times more potent than the latter while at the same time being half as toxic in laboratory animals.".
- Q3714813 label "Doxefazepam".
- Q3714813 depiction Doxefazepam.svg.